10 Manfaat Bawang Putih untuk Penyembuhan (I)

10 Manfaat Bawang Putih untuk Penyembuhan (I)
SENIN, 26 MARET 2012 12:55 wib
Gustia Martha Putri

Bawang putih (Foto: Google)
BAWANG putih merupakan salah satu bumbu dasar masakan peneman bawang merah. Selain meningkatkan kualitas rasa, bawang putih memiliki khasiat menyembuhkan beberapa penyakit.

Aroma dari bawang putih memang menyengat dan mungkin tidak terlalu disukai. Tetapi bawang putih memiliki efek penyembuhan yang hebat. Tanaman ini bisa menjadi ramuan obat untuk melawan penyakit dan menyembuhkan masalah kulit.

Berikut manfaat dari bawang putih dalam memberikan efek penyembuhan, sebagaimana dilansir Boldsky, Senin (26/3/2012).

Detoksifikasi dengan jus bawang putih

Ups, jangan mengernyitkan dahi dahulu! Jus bawang putih memang terdengar menyeramkan bagi yang belum pernah mencoba dan mendapatkan manfaatnya. Tapi, jus bawang putih memiliki beberapa manfaat kesehatan karena dapat mengeluarkan racun dari tubuh melalui pori-pori kulit.

Menjaga kesehatan jantung

Bawang putih sangat baik untuk pasien jantung. Sulfida dalam bawang putih menurunkan kadar kolesterol LDL sehingga mencegah penyakit kardiovaskuler seperti serangan jantung atau penyumbatan.

Memberi manfaat bagi penderita diabetes

Jika Anda penderita diabetes, baik untuk mengonsumsi beberapa siung bawang putih dalam menu makan harian. Bawang putih bermanfaat bagi kesehatan Anda dengan meningkatkan tingkat insulin dalam aliran darah.

Mengandung Allicin, si pelindung dari infeksi

Allicin dalam bawang putih merupakan senyawa anti-jamur yang melindungi tubuh dari infeksi dan meningkatkan antibodi.

Menjaga kesehatan telinga

Jika Anda memiliki infeksi atau sakit pada telinga, bawang putih dapat membantu Anda. Teteskan dua hingga tiga tetes minyak bawang putih hangat hasil ekstrak. Antioksidan dalam bawang putih membunuh bakteri dan mengeluarkan kotoran di dalamnya.
(TTY)

Antidepresan mungkin membantu rehabilitasi Stroke

Antidepresan mungkin membantu rehabilitasi Stroke
View Understanding Stroke Slideshow Pictures
Memahami Stroke tampilan slide gambar Understanding Stroke Slideshow Pictures
Take the Stroke Quiz Take the Stroke Quiz

Pasien stroke mengambil Prozac pulih fungsi fisik lebih daripada orang-orang di plasebo

Oleh Brenda Goodman
Berita WebMD kesehatan

Ditinjau oleh Laura J. Martin, MD

9 Januari 2011--Penelitian baru menunjukkan bahwa serotonin selektif reuptake inhibitor (SSRI) antidepresan dapat membantu orang-orang yang bergerak lagi setelah stroke.

"Saya pikir studi cukup menarik," kata Robert Robinson, MD, neuropsychiatrist yang adalah Ketua Paul Penningroth psikiatri di University of Iowa. "Ini adalah sidang terbesar untuk tanggal yang telah menunjukkan bahwa penggunaan antidepresan obat dapat menambah pemulihan fisik dari stroke."

Penelitian tersebut adalah bagian dari cache kecil tapi tumbuh bukti yang menunjukkan bahwa SSRI antidepresan obat seperti Celexa, Lexapro, Paxil, Prozacdan Zoloft dapat membantu pasien stroke tidak hanya oleh meredakan gejala suasana hati, yang dapat menghalangi pemulihan dalam hak mereka sendiri dengan menyebabkan orang merasa putus asa dan lelah, tetapi juga oleh membantu neuron, tumbuh dan membangun kembali koneksi dalam otak yang penting untuk fungsi fisik.

Jika lebih lanjut penelitian terus mengkonfirmasi temuan, para ahli mengatakan SSRI antidepresan akan hanya jenis kedua terapi obat ditemukan untuk menawarkan manfaat apapun kepada pasien stroke.

Obat yang paling umum, bekuan buster, yang harus diberikan dalam jam stroke efektif; dan studi menyarankan hingga 90% dari orang-orang yang memiliki stroke tidak mendapatkan ke rumah sakit cepat cukup untuk mendapatkan keuntungan dari itu.
Peningkatan yang signifikan dalam fungsi

Studi baru yang diterbitkan dalam The Lancet, melihat peningkatan kelumpuhan dan kelemahan dalam 118 pasien stroke iskemik di Perancis yang secara acak untuk menerima baik 20 miligram Prozac atau plasebo setiap hari selama tiga bulan, mulai 5-10 hari setelah stroke onset. Semua studi peserta menerima terapi fisik.

Rata-rata, setelah 90 hari, pasien dalam kelompok Prozac telah meningkat 34 poin pada skala gejala 100 titik stroke. Pasien dalam kelompok plasebo, di sisi lain, melihat perbaikan 24-titik. Perbaikan tetap bahkan ketika peneliti disesuaikan hasil studi untuk mengecualikan pasien yang telah dikembangkan depresi. Studi ini disponsori oleh pemerintah Perancis.

Para ahli mengatakan temuan berarti SSRI antidepresan obat dapat membuat perbedaan antara seseorang membutuhkan bantuan untuk keluar dari tempat tidur atau berjalan dan mampu melakukan kegiatan sehari-hari mereka sendiri.

"Kita tidak berbicara tentang beberapa poin pada skala seperti yang terjadi di penyakit Alzheimer di mana peningkatan hampir tak terlihat," mengatakan Robinson, yang turut menulis sebuah editorial pada studi. "Kita berbicara tentang pasien yang seluruh kategori yang ditingkatkan. Kita berbicara tentang perbaikan klinis dan secara signifikan lebih besar untuk pasien dan keluarga mereka."

Robinson telah melakukan penelitian serupa, satu dengan obat Prozac dan lain dengan obat Lexapro, yang diikuti pasien untuk setahun setelah stroke mereka.

Bahkan ketika Anda berhenti obat, pemulihan terus untuk setidaknya lain sembilan bulan," katanya.
Bagaimana antidepresan dapat menyembuhkan otak

Robinson mengatakan dia percaya bahwa antidepresan SSRI dapat membantu untuk menyembuhkan otak setelah stroke dalam dua cara.

"Jika Anda memiliki stroke, sel-sel glial, putih sel dalam otak, melepaskan protein peradangan," Robinson mengatakan. "Antidepresan mengurangi jumlah Peradangan diproduksi oleh stroke."

Obat-obatan kemudian mendorong pertumbuhan baru sel saraf, disebut neuron, dan meningkatkan hubungan antara sel-sel saraf. Tindakan ini pada dasarnya rewire otak, membuatnya lebih baik dapat terhubung dengan seluruh tubuh.
SSRI antidepresan relatif aman, murah

Roger Bonomo, MD, Direktur perawatan stroke pada Lenox Hill Hospital di New York City, yang tidak terlibat dalam studi, mencatat bahwa banyak orang sudah diberi antidepresan setelah stroke mereka, meskipun mereka biasanya diresepkan untuk mengobati depresi, yang dapat menjadi masalah umum setelah cedera otak.

Perawatan orang dengan stroke dengan antidepresan bukanlah begitu baru. Ini adalah gagasan bahwa Anda dapat membantu mereka bermotor fungsi adalah apa baru di sini, "Bonomo mengatakan.

"Saya pikir apa juga penting tentang subjek adalah bahwa hal itu berarti bahwa orang mungkin perlu obat-obatan," katanya. "Terapi bicara sepertinya tidak akan cukup."

Dia mengatakan SSRI antidepresan memiliki efek samping yang relatif sedikit, sehingga mereka risiko rendah bahkan bagi orang-orang dengan penyakit kardiovaskular.

SUMBER:

Chollet, F. The Lancet, diterbitkan online 9 Januari 2011.

Robert Robinson, MD, University of Iowa, Iowa City.

Roger Bonomo, MD, Lenox Hill Hospital, New York City.

© 2011 WebMD, LLC. All rights reserved.




Stroke Patients Taking Prozac Recovered More Physical Function Than Those on Placebo
http://www.rxlist.com/script/main/art.asp?articlekey=124508
By Brenda Goodman
WebMD Health News

Reviewed By Laura J. Martin, MD

Jan. 9, 2011 -- New research suggests that selective serotonin reuptake inhibitor (SSRI) antidepressants may help people move again after a stroke.

“I think the study is quite exciting,” says Robert Robinson, MD, a neuropsychiatrist who is the Paul Penningroth chair of psychiatry at the University of Iowa. “It is the largest trial to date that has demonstrated that the use of an antidepressant medication can augment the physical recovery from stroke.”

The study is part of a small but growing cache of evidence that suggests that SSRI antidepressant medications such as Celexa, Lexapro, Paxil, Prozac, and Zoloft may help stroke patients not simply by relieving mood symptoms, which can hinder recovery in their own right by causing people to feel hopeless and tired, but also by helping neurons grow and re-establish connections in the brain that are vital for physical functioning.

If further research continues to confirm the finding, experts say SSRI antidepressants would be only the second kind of drug therapy found to offer any benefit to stroke patients.

The most common drug, a clot buster, must be administered within hours of the stroke to be effective; and studies suggest up to 90% of people who have strokes don't get to the hospital fast enough to benefit from it.

Significant Improvement in Function
The new study, which is published in The Lancet, looked at improvements in paralysis and weakness in 118 ischemic stroke patients in France who were randomly assigned to receive either 20 milligrams of Prozac or a placebo each day for three months beginning 5-10 days after stroke onset. All study participants received physical therapy.

On average, after 90 days, patients in the Prozac group had improved 34 points on a 100-point stroke symptom scale. Patients in the placebo group, on the other hand, saw a 24-point improvement. The improvement remained even when researchers adjusted the study results to exclude patients who'd developed depression. The study was sponsored by the French government.

Experts say the finding means SSRI antidepressant medications could make the difference between someone needing help to get out of bed or to walk and being able to do those daily activities on their own.

“We're not talking about a couple of points on the scale as happens in Alzheimer's disease where the improvement in barely noticeable,” says Robinson, who co-authored an editorial on the study. “We're talking about patients who are a whole category improved. We're talking about clinically and significantly bigger improvement for the patient and their family.”

Robinson has conducted similar studies, one with the drug Prozac and other with the drug Lexapro, which followed patients for up to a year after their strokes.

“Even when you stop the drug, the recovery continues for at least another nine months,” he says.

How Antidepressants May Heal the Brain
Robinson says he believes that SSRI antidepressants may help to heal the brain after a stroke in two ways.

“If you have a stroke, the glial cells, the white cells in the brain, release these inflammatory proteins,” Robinson says. “Antidepressants decrease the amount of inflammation produced by the stroke.”

The drugs then encourage the growth of new nerve cells, called neurons, and increase the connections between nerve cells. These actions essentially rewire the brain, making it better able to connect with the rest of the body.

SSRI Antidepressants Relatively Safe, Inexpensive
Roger Bonomo, MD, director of stroke care at Lenox Hill Hospital in New York City, who was not involved in the study, notes that many people are already given antidepressants after their strokes, though they are usually prescribed to treat depression, which can be a common problem after brain injury.

“The treatment of people with strokes with antidepressants is not so new. It's the idea that you can help their motor function is what's new here,” Bonomo says.

“I think what's also important about the subject is that it means that people probably need medication,” he says. “Talk therapy doesn't seem to be sufficient.”

He says SSRI antidepressants have relatively few side effects, so they are low risk even for people with cardiovascular disease.

SOURCES:

Chollet, F. The Lancet, published online Jan. 9, 2011.

Robert Robinson, MD, University of Iowa, Iowa City.

Roger Bonomo, MD, Lenox Hill Hospital, New York City.

© 2011 WebMD, LLC. All rights reserved.

Can Herbs Fight Asthma?

Can Herbs Fight Asthma?
Preliminary Research Suggests They Can, but Further Study Needed
By Charlene Laino
WebMD Health News Reviewed by Brunilda Nazario, MD
http://www.webmd.com/asthma/news/20120305/can-herbs-fight-asthma
March 5, 2012 (Orlando, Fla.) -- A traditional Chinese herbal remedy known as kampo helped to relieve daily asthma symptoms in nearly all of more than 200 people studied, Japanese researchers report.

North American allergy experts tell WebMD that although they find the preliminary findings fascinating, further study is needed before they would recommend the herbs.

Yoshiteru Shimoide, MD, head of the Yoshiteru Shimoide Clinic of Internal Medicine in Kagoshima City, Japan, presented the results here at the annual meeting of the American Academy of Allergy, Asthma, & Immunology (AAAAI).

Slideshow: 10 Worst Cities for Asthma, 2011
Asthma on the Rise in U.S.
The number of people in the U.S. with asthma is growing. One in 12 people had asthma in 2009, compared with 1 in 14 in 2001, according to the CDC.

There is no cure, but most people can control their symptoms, reduce the severity of their disease, and prevent asthma attacks by avoiding asthma triggers and correctly using prescribed medicines, such as steroid inhalers, the CDC says.

There's much room for improvement, Shimoide says. He says it was accidentally discovered that kampo herbs could wipe out symptoms in many people while testing the ancient remedy against an allergic skin disorder known as atopic dermatitis.

So his team studied 278 people with asthma who suffered daily symptoms of the disease. Of those, 52 were given standard treatment (typically an inhaled steroid and a bronchodilator), and 226 were treated with kampo herbs.

Symptoms completely disappeared in 94% of patients taking kampo herbs after an average of 16 days, Shimoide says.

In contrast, about three-fourths of those taking standard asthma medications still had daily wheeze and other symptoms.



Side Effects Still Need Study
The study did not look at possible side effects of kampo herbs. But a major problem facing kampo medicine is herbal product quality. There have been cases in which poisonous plants found their way into the herbal mix, resulting in kidney damage, for example.

In kampo medicine, most herbs are taken as a fixed formula. Each individual herb is thought to address a particular imbalance in an ill person.

Herbs used in the current study include Scutellaria root, Coptis rhizome, gardenia fruit, hoelen, cinnamon bark, and Glycyrrhiza (aka licorice) root.

Asked to comment on the findings, Peter Creticos, MD, of Johns Hopkins University in Baltimore, tells WebMD: "This is a fascinating observation. We now need further study."

One of the big problems with this preliminary work is that people knew if they were taking the herbs, Creticos says. If people are given a drug or an herb that they think will help fight their disease, up to 40% will report they were indeed helped, Creticos explains.

Also, don't try this at home, he cautions. Until there is further study looking at the safety of the herbal formula, people should only take the herbs as part of a clinical trial, Creticos says.

Still, the AAAAI does think there is evidence for herbal therapy having an anti-inflammatory effect that would fight asthma's underlying cause and is supporting research in the field, says William Silvers, MD, former head of the group's committee on complementary and alternative medicine.

These findings were presented at a medical conference. They should be considered preliminary as they have not yet undergone the "peer review" process, in which outside experts scrutinize the data prior to publication in a medical journal.

China: Parents struggle for autistic kids

China: Parents struggle for autistic kids Tian Ying http://www.autismsupportnetwork.com/news/china-parents-struggle-autistic-kids-autism-22938234 China has no public schools specifically for autistic children so they are taught or treated in schools with others who are mentally challenged. By 2012 the government aims to build facilities in 31 pilot cities, Tian Ying reports. In an outdoor gym class in Beijing, parents are holding their young ones' arms and helping them follow the teacher's moves. None of the autistic kids are focusing on the teacher as they move awkwardly - gently pulled this way and that by their parents. In this nursery mainly for autistic children, parents accompany their kids all day long. Autism is a neural disorder characterized by impaired social interaction and communication, and repetitive behavior. The nursery belongs to the public-funded Beijing Chaoyang Anhua Intelligence Training School, where about one third of the 165 students suffer from autism. Since there are no public schools specifically for autistic children, these kids are taught together with others who are mentally challenged. According to WHO statistics, there are 600,000 to 1.8 million children with autism in China. But some scholars believe that the number might be several millions higher. When the kids are taking a nap at noon, 40-year-old Liu Jianhua is mopping his son's classroom floor and tidying up the toys. He volunteers and takes turns with his wife to look after their son. Now I'm pleased to see that my boy wants to hug his daddy occasionally, but before attending the school he treated me just like another person," he says. His five-year-old boy, Liu Shuai, doesn't talk and needs to be looked after constantly. Generally, unlike normal kids, autistic children seem emotionally detached from their parents, never showing intimacy. However, this doesn't make Liu Jianhua love his son any less. "What really worries me is my boy's future, especially when his mother and I are not with him anymore. Who will look after him?" asks Liu. Another parent Zhong Xueping says outside the classroom, "I dare not even think about it." In the classroom, his four-year-old boy Zhong Chuangli is waving his right hand, unaware of what the teacher is doing. Zhong Xueping says he has no idea if the training will help his boy, all he can do is to give his son the best he can afford - a huge financial burden for him. Anhua's tuition is 1,500 yuan (US$220) a month, roughly half the average salary in Beijing in 2009. Tuition at private schools can be double or triple that. Even the cost of the public schools can nearly bankrupt a family, as only one parent usually has time to work, while the other must look after their child all the time. To add to their struggle, some families have to leave their hometown and rent flats in big cities to ensure their children get proper care. Zhong Xueping's family is from Hubei Province. He and his wife sell clothes in Beijing for a living. "We barely make ends meet after the tuition is paid, and we can only afford to rent a small basement," he says. As to the kids' future, Long Jianyou, the principal of Anhua School, says: "In the best-case scenario, graduates from Anhua's vocational high school can find employment." Anhua caters for children from pre-school through high school. This year, 12 of the graduates have already found jobs in reputable hotels, doing simple jobs such as changing bed sheets. They could earn as much as 1,700 yuan a month, says Long. The employers offering jobs to our kids are all China-based foreign companies," says Long. There is not a single domestic company doing this. They might employ physically disabled persons, but never those who are mentally challenged," he says, citing widespread misunderstanding of autism. Zhong Xueping says his family is discriminated against because people think their child is some kind of lunatic. "We sell clothes in a market, and when my boy crawls into others' stands, they shun him as if he's an idiot." Talking about their child's future, Wang Hongli, mother of a 10-year-old boy who's just started to exhibit symptoms of autism, believes her son could do a lot better. She hopes one day her boy can socialize like normal kids. She's going to send her son back to regular school this autumn. But he will probably need a tutor, which could cost 2,000 yuan a month at least. Wang comes from a small city in northeast China's Liaoning Province. Because there is no special school in her hometown, she took time off from work and took her boy all the way to Beijing for treatment and schooling. Even in Beijing, there were no special schools for young children suffering for autism six years ago. Long, the Anhua principal, says: "We only realized recently that the earlier autism is diagnosed and treated, the better people fare later in life, so we started this autistic nursery." China has incorporated a plan for training autistic children into the country's development blueprint for 2006-2012, which specifies the building of autism training facilities in 31 pilot cities, and training professionals to diagnose, train and teach autistic children. From Shanghai Daily Read more: http://www.autismsupportnetwork.com/news/china-parents-struggle-autistic-kids-autism-22938234#ixzz1yC1KRv86

Antioxidant N-Acetylcysteine Lowers Irritability and Reduces Repetitive Behaviors Associated With Autism http://neurosciencenews.com/nac-autism-treatment-antioxidant-psychology/ Antioxidant shows promise as treatment for certain features of autism, Stanford study finds A specific antioxidant supplement may be an effective therapy for some features of autism, according to a pilot trial from the Stanford University School of Medicine and Lucile Packard Children’s Hospital that involved 31 children with the disorder. The antioxidant, called N-Acetylcysteine, or NAC, lowered irritability in children with autism as well as reducing the children’s repetitive behaviors. The researchers emphasized that the findings must be confirmed in a larger trial before NAC can be recommended for children with autism. Irritability affects 60 to 70 percent of children with autism. “We’re not talking about mild things: This is throwing, kicking, hitting, the child needing to be restrained,” said Antonio Hardan, MD, the primary author of the new study. “It can affect learning, vocational activities and the child’s ability to participate in autism therapies.” The study appears in the June 1 issue of Biological Psychiatry. Hardan is an associate professor of psychiatry and behavioral sciences at Stanford and director of the Autism and Developmental Disabilities Clinic at Packard Children’s. Stanford is filing a patent for the use of NAC in autism, and one of the study authors has a financial stake in a company that makes and sells the NAC used in the trial. Antioxidant N-Acetylcysteine (NAC) might prove to be an effective treatment for some of the symptoms associated with Autism. Image adapted from Commons Wikimedia user MesserWoland. Finding new medications to treat autism and its symptoms is a high priority for researchers. Currently, irritability, mood swings and aggression, all of which are considered associated features of autism, are treated with second-generation antipsychotics. But these drugs cause significant side effects, including weight gain, involuntary motor movements and metabolic syndrome, which increases diabetes risk. By contrast, side effects of NAC are generally mild, with gastrointestinal problems such as constipat The state of drug treatments for autism’s core features, such as social deficits, language impairment and repetitive behaviors, is also a major problem. “Today, in 2012, we have no effective medication to treat repetitive behavior such as hand flapping or any other core features of autism,” Hardan said. NAC could be the first medication available to treat repetitive behavior in autism — if the findings hold up when scrutinized further. The study tested children with autism ages 3 to 12. They were physically healthy and were not planning any changes in their established autism treatments during the trial. In a double-blind study design, children received NAC or a placebo for 12 weeks. The NAC used was a pharmaceutical-grade preparation donated by the neutraceutical manufacturer BioAdvantex Pharma. Subjects were evaluated before the trial began and every four weeks during the study using several standardized surveys that measure problem be During the 12-week trial, NAC treatment decreased irritability scores from 13.1 to 7.2 on the Aberrant Behavior Checklist, a widely used clinical scale for assessing irritability. The change is not as large as that seen in children taking antipsychotics. “But this is still a potentially valuable tool to have before jumping on these big guns,” Hardan said. In addition, according to two standardized measures of autism mannerisms and stereotypic behavior, children taking NAC showed a decrease in repetitive and stereotyped behaviors. “One of the reasons I wanted to do this trial was that NAC is being used by community practitioners who focus on alternative, non-traditional therapies,” Hardan said. “But there is no strong scientific evidence to support these interventions. Somebody needs to look at them.” Hardan cautioned that the NAC for sale as a dietary supplement at drugstores and grocery stores differs in some important respects from the individually packaged doses of pharmaceutical-grade NAC used in the study, and that the over-the-counter version may not produce the same results. “When you open the bottle from the drugstore and expose the pills to air and sunlight, it gets oxidized and becomes less effective,” he said. Although the study did not test how NAC works, the researchers speculated on two possible mechanisms of action. NAC increases the capacity of the body’s main antioxidant network, which some previous studies have suggested is deficient in autism. In addition, other research has suggested that autism is related to an imbalance in excitatory and inhibitory neurotransmitters in the brain. NAC can modulate the glutamatergic family of excitatory neurotransmitters, which might be useful in autism. The scientists are now applying for funding to conduct a large, multicenter trial in which they hope to replicate their findings. “This was a pilot study,” Hardan said. “Final conclusions cannot be made before we do a larger trial.” About this neuroscience research article HardanÆs collaborators at Stanford were Lawrence Fung, MD, a psychiatry resident; Robin Libove and Surekha Nair, MD, social science research assistants; postdoctoral scholar Tetyana Obukhanych, PhD; Lenore Herzenberg, DSc, professor of genetics and member of the Stanford Cancer Institute; and Rabindra Tirouvanziam, PhD, a former instructor in pediatric pulmonary medicine at Stanford who is now at the Emory University School of Medicine. The research was supported by a grant from the Escher Family Fund at t Information about the Stanford Autism Center at Packard Children’s Hospital and the Department of Psychiatry and Behavioral Sciences, which also supported the research, is available online at http://autism.lpch.org. The Stanford University School of Medicine consistently ranks among the nation’s top medical schools, integrating research, medical education, patient care and community service.